The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery
P. Lewis White(University Hospital of Wales), Rosemary A. Barnes(Innsbruck Medical University), Malcolm Finkelman, Raquel Posso(Public Health Wales), Jessica S. Price(Public Health Wales), Christian Parr(Cardiff University)
Cited by 10
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
|PubMed|1991|340
Aspergillus PCR: One Step Closer to Standardization
|Journal of Clinical Microbiology|2010|295